ReviewCancers2022
Overcoming Resistance: FLT3 Inhibitors Past, Present, Future and the Challenge of Cure.
Debora Capelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it
ReviewCancers2022
Debora Capelli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.